You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Mallinckrodt
Dow
Medtronic
Baxter

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

GVOKE PFS Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Gvoke Pfs patents expire, and when can generic versions of Gvoke Pfs launch?

Gvoke Pfs is a drug marketed by Xeris and is included in one NDA. There is one patent protecting this drug.

This drug has fifteen patent family members in twelve countries.

The generic ingredient in GVOKE PFS is glucagon. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the glucagon profile page.

US ANDA Litigation and Generic Entry Outlook for Gvoke Pfs

A generic version of GVOKE PFS was approved as glucagon by LILLY on September 11th, 1998.

  Start Trial

Summary for GVOKE PFS
International Patents:15
US Patents:1
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
Drug Prices: Drug price information for GVOKE PFS
DailyMed Link:GVOKE PFS at DailyMed
Drug patent expirations by year for GVOKE PFS
Drug Prices for GVOKE PFS

See drug prices for GVOKE PFS

US Patents and Regulatory Information for GVOKE PFS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xeris GVOKE PFS glucagon SOLUTION;SUBCUTANEOUS 212097-001 Sep 10, 2019 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Xeris GVOKE PFS glucagon SOLUTION;SUBCUTANEOUS 212097-002 Sep 10, 2019 RX Yes Yes   Start Trial   Start Trial   Start Trial
Xeris GVOKE PFS glucagon SOLUTION;SUBCUTANEOUS 212097-001 Sep 10, 2019 RX Yes Yes   Start Trial   Start Trial   Start Trial
Xeris GVOKE PFS glucagon SOLUTION;SUBCUTANEOUS 212097-002 Sep 10, 2019 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Dow
Medtronic
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.